Business Context and Reporting Period
This Form 8-K was filed by Onconova Therapeutics, Inc. on August 18, 2017, reporting an event that occurred on August 14, 2017. The Company is an emerging growth company incorporated in Delaware. The filing addresses a regulatory compliance issue regarding its listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing references financial data from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2017.
- Stockholders' Equity: Approximately $0.4 million.
- Nasdaq Minimum Requirement: $2.5 million (Rule 5550(b)(1)).
- Compliance Status: The Company does not meet the minimum stockholders' equity requirement, nor does it meet alternative standards for market value of listed securities or net income from continuing operations.
The filing text does not provide specific values for revenue, profit, cash flow, margins, or debt.
Material Changes and Events
On August 14, 2017, the Company notified Nasdaq of its noncompliance with the minimum stockholders' equity requirement. On August 16, 2017, Nasdaq confirmed this noncompliance in writing. This notification has no immediate effect on the listing of the Company's securities.
Outlook, Risks, and Contingencies
Compliance Timeline:
- Plan Submission Deadline: October 2, 2017 (45 calendar days from notification).
- Potential Extension: If a plan is accepted, Nasdaq may grant an extension until November 15, 2017, to regain compliance.
- Delisting Risk: If the plan is not accepted, the extension is not granted, or compliance is not achieved by the deadlines, Nasdaq may initiate delisting proceedings.
- Hearing Option: The Company may request a hearing before an independent Hearings Panel, which could grant an additional extension of up to 180 calendar days.
Management Commentary: The Company is evaluating various courses of action to regain compliance and intends to submit a plan timely. However, management states there can be no assurance that the plan will be accepted or that the Company will successfully maintain its listing.
Investor Verification Checklist
- Verify the Company's current stockholders' equity as of the most recent financial report.
- Monitor the submission of the compliance plan to Nasdaq by the October 2, 2017 deadline.
- Review the Company's strategy for raising capital or restructuring to meet the $2.5 million equity threshold.
- Check for any subsequent announcements regarding the acceptance of the compliance plan or potential delisting notices.